FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 353:839-841 August 25, 2005 Number 8 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Watanabe, D. PubMed Citation

Visual loss is often considered the most feared complication of human disease, other than death. In 2002, 124 million people worldwide had poor vision and 37 million were blind.¹ In developed countries, the primary causes of visual loss are age-related macular degeneration, in the elderly, and diabetic retinopathy, in working-age persons. It is estimated that diabetes mellitus affects 4 percent of the world's population, almost half of whom have some degree of diabetic retinopathy at any given time. Visual loss primarily occurs from either proliferation of new retinal vessels (proliferative diabetic retinopathy) or increased permeability of retinal vessels (diabetic macular . . . [Full Text of this Article]

Source Information

From the Beetham Eye Institute and Eye Research Section, Joslin Diabetes Center, and the Department of Ophthalmology, Harvard Medical School — both in Boston.

This article has been cited by other articles:

• Wang, S., Gottlieb, J. L., Sorenson, C. M., Sheibani, N. (2009). Modulation of Thrombospondin 1 and Pigment Epithelium-Derived Factor Levels in Vitreous Fluid of Patients With Diabetes. Arch Ophthalmol 127: 507-513 [Abstract] [Full Text]  
• Eckardt, K.-U. (2009). Erythropoietin and microvascular diabetic complications. Nephrol Dial Transplant 24: 388-390 [Full Text]  
• Diabetic Retinopathy Clinical Research Network, (2009). Observational Study of the Development of Diabetic Macular Edema Following Panretinal (Scatter) Photocoagulation Given in 1 or 4 Sittings. Arch Ophthalmol 127: 132-140 [Abstract] [Full Text]  
• Tong, Z., Yang, Z., Patel, S., Chen, H., Gibbs, D., Yang, X., Hau, V. S., Kaminoh, Y., Harmon, J., Pearson, E., Buehler, J., Chen, Y., Yu, B., Tinkham, N. H., Zabriskie, N. A., Zeng, J., Luo, L., Sun, J. K., Prakash, M., Hamam, R. N., Tonna, S., Constantine, R., Ronquillo, C. C., Sadda, S., Avery, R. L., Brand, J. M., London, N., Anduze, A. L., King, G. L., Bernstein, P. S., Watkins, S., Genetics of Diabetes and Diabetic Complication Stu, , Jorde, L. B., Li, D. Y., Aiello, L. P., Pollak, M. R., Zhang, K. (2008). Promoter polymorphism of the erythropoietin gene in severe diabetic eye and kidney complications. Proc. Natl. Acad. Sci. USA 105: 6998-7003 [Abstract] [Full Text]  
• Kase, S., Saito, W., Ohgami, K., Yoshida, K., Furudate, N., Saito, A., Yokoi, M., Kase, M., Ohno, S. (2007). Expression of erythropoietin receptor in human epiretinal membrane of proliferative diabetic retinopathy. Br J Ophthalmol 91: 1376-1378 [Abstract] [Full Text]  
• Nishiguchi, K. M., Nakamura, M., Kaneko, H., Kachi, S., Terasaki, H. (2007). The Role of VEGF and VEGFR2/Flk1 in Proliferation of Retinal Progenitor Cells in Murine Retinal Degeneration. IOVS 48: 4315-4320 [Abstract] [Full Text]  
• Hernandez, C., Fonollosa, A., Garcia-Ramirez, M., Higuera, M., Catalan, R., Miralles, A., Garcia-Arumi, J., Simo, R. (2006). Erythropoietin Is Expressed in the Human Retina and It Is Highly Elevated in the Vitreous Fluid of Patients With Diabetic Macular Edema.. Diabetes Care 29: 2028-2033 [Abstract] [Full Text]